Multiple Tissue Engineering Payloads Selected Through ISS National Lab & NSF Joint Solicitation

KENNEDY SPACE CENTER (FL), October 7, 2019 – The International Space Station (ISS) U.S. National Laboratory and the National Science Foundation (NSF) today announced that five research investigations have been selected from a joint solicitation to leverage the microgravity environment of the orbiting laboratory for tissue engineering and mechanobiology research.

The ISS National Lab and NASA will facilitate hardware implementation and in-orbit access to the orbiting laboratory. NSF will fund the selected projects to advance fundamental science and biomedical engineering knowledge (up to $2 million in total). NSF supports transformative research to help drive the U.S. economy, enhance national security, and maintain America’s position as a global leader in innovation.

This solicitation marked the second collaboration between the ISS National Lab and NSF seeking proposals in the areas of cellular engineering, tissue engineering, and the modeling of physiological or pathophysiological systems that could be enhanced through sustained exposure to microgravity. The end goal was to select investigations that would help propel transformative research and lead to advances in the understanding of disease and in the development of novel therapies to improve life on Earth. Below are the selected proposals: 

ISS: Cellular Mechanotransduction by Osteoblasts in Microgravity
Principal Investigator (PI): Allen Po-Chih Liu
University of Michigan

ISS: Microphysiologic Model of Human Cardiovascular Stiffness-Related Diseases in Microgravity
PI: Kevin Costa (Co-PI: David Sachs)
Icahn School of Medicine at Mount Sinai

ISS/Collaborative Research: Studying the Effects of Microgravity on 3D Cardiac Organoid Cultures
PIs: Binata Jodder and Munmum Chattopadhyay
University of Texas at El Paso and Texas Tech University Health Science Center

This is a collaborative project between the University of Texas at El Paso and the Texas Tech University Health Science Center.

ISS: Engineering Stem Cell-Derived Cardiac Microtissues with Metabolic Regulators in Space to Promote Cardiomyocyte Maturation
PI: Chunhui Xu
Emory University

ISS: Tissue Engineered Liver Immune Chips in Microgravity as a Novel Platform to Study the Effect of Aging
PI: Tobias Deuse
University of California at San Francisco

“The ISS National Lab is honored to work alongside the NSF to support fundamental research in biomedical engineering and mechanobiology in space that promises to create knowledge and accelerate discovery on Earth,” said ISS National Lab Interim Chief Scientist Dr. Michael Roberts. “Each of these investigations adds to our already stellar set of multidisciplinary ISS National Lab payloads selected by the NSF for basic science that will transform the future.”

All grants and subsequent flight opportunities are contingent on final contract agreements between the award recipients, the ISS National Lab, and NSF.

To learn more about the capabilities of the ISS National Lab, including past research initiatives and available facilities, visit www.ISSNationalLab.org.

About the International Space Station (ISS) U.S. National Laboratory: In 2005, Congress designated the U.S. portion of the ISS as the nation’s newest national laboratory to optimize its use for improving quality of life on Earth, promoting collaboration among diverse users, and advancing science, technology, engineering, and mathematics (STEM) education. This unique laboratory environment is available for use by non-NASA U.S. government agencies, academic institutions, and the private sector. The ISS National Lab manages access to the permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space.